ГОСТ Р ИСО 10993.4-99
117| Cooper. S. R., Fabrizius, D. J. and Grascl. T. G.. Methods of assessment of thrombosis ex vivo. In:
Leonard E. F., Turitto V. T.. and Vroman L. (Eds): Blood in contact with natural and artificial surfaces. Ann N. Y. Acad
Sciences 516: 572-585, 1987
118| Corriveau. D. M. and Fritsma. G. A. (Eds): Haemostasis and thrombosis in the clinical laboratory.).
B.Lippincott. Philadelphia. 1988. 443 pp
|!9| Dawids. S ct al. (cds): Test procedures for the blood compatibility of biomaterials. In preparation, 1992
(20) Dewanjec, M. K.. Methods of assessment of thrombosis in vivo, In: Leonard E. F., Turitto V. T. and
Vroman L. (Eds): Blood in contact with natural and artificial surfaces. Ann N. Y. Acad Sciences, 516: 541—571, 1987
|21| Dewanjec, M. K., Kapadvanjwala. M. and Sanchez, A. Quantiation of comparative thrombogcnicity of dog,
pig, and human platelets in a hcmodialyzer. Am Soc Artif Int Organs Journal 38: 88—90, 1992
(221 Didisheim, P., Dewanjec. M. K.. Frisk, C. S.. Kaye. M. P. and Fass, D. N.. Animal models for predicting
clinical pcifomancc of biomaterials for cardiovascular use. In: Borctos J. W. and Eden M. (Eds): Contemporary
Biomaterials. Noyes Publications. Park Ridge. NJ, USA, pp. 132—179, 1984
|23| Didisheim. P.. Dewanjec, M. K., Kaye. M. P.. Frisk. C. S., Fass. D. N.. Tirrcll. M. V. and Tollman. P. E.,
Nonpredictability of long-term in vivo response from short-term in vitro or ex vivo blood/matcrial interactions. Trams
Am Soc Artif Int Organs 30: 370—376. 1984
|24| Didisheim, P.. Olsen. D. B„ Farrar, D. J., Portner, P. M., Griffith, В. P.. Pennington. D. G., Joist. J. IL,
Schocn. Gristina, A. G. and Anderson, J. M.. Infections and thromboembolism with implantable cardiovascular devices.
Trans Am Soc Artif Int Organs 35: 54—70. 1989
|25| Didisheim. P., Stropp. J. Q„ Borowick. J. H. and Grabowski, E. F.. Species differences in platatet adhesion
to materials: investigation by a two-stage technique, Trans Am Artif Int Organs 2: 124—132. 1979
(26) Guidelines for blood/material interactions. Report of the National Heart, Lung and Blood Institute Working
Group. U. S. Department of Health and Human Services. Public Health Service. National Institutes of Health. NIH
Publication No. 85—2185, revised September 1985. Available from Biomaterials Program, Devices and Technology Branch,
Division of Heart and Vascular Diseases, NHLBI. 312 Federal Building. 7550 Wisconsin Avenue, Bethesda, MD 20892,
USA; phone 301-496-1586. FAX 301-480-6282
[271 Harker, L. A.. Kelly, A. B. and Hanson. S. R., Expcrimantal arterial thrombosis in nonhuman primates.
Circulation 83. Supplement IV, 41—55, 1991
|28| Harker. L. A., Malpass, T. W.. Branson, H. E., HesseI. E. A. and Slichtcr. S. J., Mechanism of abnormal
bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective
alpha granule release. Blood 56: 824—834. 1980
|29| Harker L. A.. Ratner B. D. and Didisheim P. (Eds): Cardiovascular Biomaterials and Biocompatibility.
Supplement to Cardiovascular Pathology. Elsevier, New York, in press 1992
|30| Karwath. R.. Schurer. M. and Wolf, H.. Measurement of pkitelct adhesiveness onto aitifial surfaces using
Cr-5l and ln-111 labelledplatelcls. Studia Biophysica 131: 117—123, 1989
[311 Kataoka, K.. Maeda. M., NLshimura. T.. Nitadori. Y., Tsuruta. T.. Akaike T. and Sakurai, Estimation of
cell adhesion on polymer surfaces with the use of «cotuinm method». J Biomed Mat Res 14: 817—823, 1980
[32| Kay. L. A. Essentials of Haemostasis and Thrombosis. Churchill Livingstone. Edinburgh. 1988. 290 pp
|33| Lewis. J. P„ Sweeney. J.. Baklini. L., Fricdland, G. H. and Salzman. E. W., Assessment of thromboresistance
of intravenous cannulac by 125 (•fibrinogen scanning. J. Biomed Mat Res 19:99. 1985
|34| Mahiout, A., Mcinhold, IL, Jorrcs, A.. Kneg. R.. Kcssel. M., Tretzel. J. and Bauermeister, U.. Ex vivo
model for prcclinical evaluation of dialvzers containing new membranes. Life Support Systems 3: suppl I, 448—452.
1985
[3S| Mialc, J. B.. Laboratory medicine hematology. Sixth edition, CV Mosby, St. Louis. 1982
136) Palatianos, G. M.. Dcwanjtt. M. K. and Robinson. R. P. et al, Quantitaion of platelet loss with Indium-111
labelled platelets in a hollow-fiber membrane oxygenator and arterial filter during extracorporeal circulation in a pig
model. Trans Am Soc Artif Int Organs 35: 667—670. 1989
(37) Schocn, F. J.. Anderson. J. M.. Didisheim. P., Dobbins, J. J., Gristina, A. G„ Harasaki. H. and Simmons.
R. L., Ventricular assist device (VAD) pathology analyses: guidelines for clinical studies. J. Applied Materials 1: 49—56.
1990
138) Schocn. F. G., Interventional and surgical cardiovascular pathology. Appendix: Pathologic analysis of the
cardiovascular system and prosthetic devices, pp 369—3%. W. B. Saunders Co., Philadelphia, 1989. (39| Spencer. P. C.,
Schmodt. B.. Sumbtlcbcn, W.. Bosch, T. and Gurland. H. J >, Ex vivo model of hemodialysis mmbranc biocompatibility.
Trans Am Soc Artif Int Organs 31: 495—498, 1985
|40| Tripartite Biocompatibility Guidance for McdicalDcvices.Prepared by toxicology sub-group ofthe Tripartite
Subcommittee on medical devices, September 1986
|4 l| Ward. R. A., Schmidt, B., Blumcnstcin, M. and Gurland. H. J., Evaluation of phagocytic cell function in an
ex vivo model of hemodialysis. Kidney International 37: 776—782. 1990
[42| White. R. A., Diagnosis and therapy of emergent vascular diseases. In: Shoemaker, W. C.. Ayres, S..
Holbrook. P. R. and Thompson, W. L.. Textbook of critical care, second edition. W.B. Saunders. Philadelphia. 1989.
pp. 447-452
23